课题基金 / 基金详情

Novel effects and mechanisms of action of heme and soy isoflavones

Novel effects and mechanisms of action of heme and soy isoflavones
血红素和大豆异黄酮的新作用和作用机制
批准号:
16500503
负责人:
OGAWA Kazuhiro
金额:
$2.37万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

OGAWA Kazuhiro的其他基金

相似基金

相关文献

中文摘要
翻译
血红素是一种广泛用于补充铁的食品化学品。作为血红蛋白和许多其他血色素蛋白的修复基,血红素是人体必需的分子。过量的游离血红素是一种促氧化剂和有毒物质,被血红素加氧酶(HO)降解为铁、一氧化碳和胆绿素,后者迅速转化为抗氧化剂胆红素。HO有两种同工酶,即诱导型HO-1和组成型HO-2。HO-1的诱导是对抗氧化应激的重要防御机制,一些HO抑制剂具有抗肿瘤活性。在这个项目中,我利用不同类型的人体细胞,评估和分析了食物化学物质如血红素铁和大豆异黄酮对血红素分解代谢的影响和作用机制。长期的低氧降低了HO-2和HO-1的表达水平,这些HOS的下调是在转录和转录后水平上引起的。SiRNA下调110-2可诱导HO-1表达,而HO-2在一定条件下下调HO-1可增加细胞内血红素含量,提示HO-2在维持细胞内血红素水平和调控HO-1表达中具有重要意义。大豆异黄酮染料木素抑制了血红素和其他化学物质对HO-1的诱导,而另一种大豆异黄酮大豆苷元在某些情况下不抑制HO-1的诱导。结合我们的其他实验结果,这些异黄酮类化合物对HO-1诱导的抑制作用可能是通过雌激素受体非依赖性机制实现的。
英文摘要
Heme is widely used as a food chemical for iron supplementation. Heme is an essential molecule for us as prosthetic groups for hemoglobin and many other hemoproteins. Excess free heme is a pro-oxidant and toxic, and is degraded by heme oxygenase (HO) to iron, CO and biliverdin, which is rapidly converted to bilirubin, an antroxidant. There are two isozymes of HO, namely inducible HO-1 and constitutive 110-2. Induction of HO-1 is an important defense mechanism against oxidative stress, and some HO inhibitors have antitumor activity. In this project, I have been evalutated the effects and analyzed the mechanisms of action of food chemicals such as heme iron and soy isoflavones on heme catabolism, using various types of human cells.Prolonged hypoxia decreased the expression level of HO-2 as well as that of HO-1, and these down-regulations of HOs were caused at both transcriptional and post-transcriptional levels. Down-regulation of 110-2 by siRNA induced the HO-1 expression, and HO-2 knock-down 1 under some conditions increased the intracellular heme content, suggesting the significance of HO-2 in the maintenance of cellular heme levels and in the regulation of HO-1 expression. Genistein, a soy isoflavone, inhibited the induction of HO-1 by heme and other chemicals, while daidzein, another soy isoflavone, did not inhibited the induction of HO-1 in some cases. Together with results of our other experiments, these inhibitory effects of isoflavones on HO-1 induction were suggested to be mediated by estrogen receptor-independent mechanism.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
ヘムオキシゲナーゼ-1誘導剤、培地製造方法、移植用臓器の保存液製造方法および実験動物生産方法
血红素加氧酶1诱导剂、培养基的制造方法、移植用器官保存液的制造方法以及实验动物的制造方法
DOI: --
发表时间: 2005
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.1016/j.bbrc.2004.05.195
发表时间: 2004-07-23
期刊: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子: 3.1
作者: [Adachi, T, Ishikawa, K, Shibahara, S]
通讯作者: Shibahara, S
DOI: --
发表时间: 2004
期刊: 大豆たん白質研究 7
影响因子: --
作者: [ZHANG, Yongzhao etal., 小川 和宏 ら]
通讯作者: 小川 和宏 ら
ヘム分解系-多彩な疾患への創薬標的-
血红素降解系统-各种疾病的药物发现目标-
DOI: --
发表时间: 2004
期刊: 日本薬理学雑誌 124
影响因子: --
作者: [ZHANG, Yongzhao etal., 小川 和宏 ら, 小川 和宏]
通讯作者: 小川 和宏
共 8 条
    Solid phase film formation of polymer/ceramic compound particles by hetero-structure control and comprehensive analysis of film formation mechanisms
    • 批准号:
      17H01235
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $28.62万
    • 财政年份:
      2017
    • 负责人:
      OGAWA Kazuhiro
    • 依托单位:
    Regulation of fatigue and stress by modulating of heme metabolism
    • 批准号:
      25560366
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2013
    • 负责人:
      OGAWA Kazuhiro
    • 依托单位:
    Map Formation for Cold Spray Conditions Based on Particle Kinetic and Rebound Energies
    • 批准号:
      23360317
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.15万
    • 财政年份:
      2011
    • 负责人:
      OGAWA Kazuhiro
    • 依托单位:
    Regulatory mech anism of heme catabolism by food constituents
    • 批准号:
      21500776
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      OGAWA Kazuhiro
    • 依托单位:
    海外基金